These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 9692650)
1. Pharmacokinetic Alterations Associated with Critical Illness. Morales Castro D; Dresser L; Granton J; Fan E Clin Pharmacokinet; 2023 Feb; 62(2):209-220. PubMed ID: 36732476 [TBL] [Abstract][Full Text] [Related]
2. A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement Therapy. Bouajram RH; Awdishu L Kidney Int Rep; 2021 Aug; 6(8):2033-2048. PubMed ID: 34386653 [TBL] [Abstract][Full Text] [Related]
3. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Roberts JA; Abdul-Aziz MH; Lipman J; Mouton JW; Vinks AA; Felton TW; Hope WW; Farkas A; Neely MN; Schentag JJ; Drusano G; Frey OR; Theuretzbacher U; Kuti JL; Lancet Infect Dis; 2014 Jun; 14(6):498-509. PubMed ID: 24768475 [TBL] [Abstract][Full Text] [Related]
4. [Clinically relevant pharmacokinetic drug interactions in the intensive care unit: an overview]. Kämmerer W Med Klin Intensivmed Notfmed; 2012 Mar; 107(2):128-40. PubMed ID: 22437193 [TBL] [Abstract][Full Text] [Related]
5. Haloperidol dosing strategies in the treatment of delirium in the critically ill. Wang EH; Mabasa VH; Loh GW; Ensom MH Neurocrit Care; 2012 Feb; 16(1):170-83. PubMed ID: 22038577 [TBL] [Abstract][Full Text] [Related]
7. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation. Mulla H; Nabi F; Nichani S; Lawson G; Firmin RK; Upton DR Br J Clin Pharmacol; 2003 Jan; 55(1):23-31. PubMed ID: 12534637 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock. De Paepe P; Belpaire FM; Buylaert WA Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864 [TBL] [Abstract][Full Text] [Related]
10. [Methods for studying the hepatic metabolism of drugs in man]. Geneve J; Bergmann JF; Caulin C; Segrestaa JM Therapie; 1990; 45(2):91-7. PubMed ID: 2191470 [TBL] [Abstract][Full Text] [Related]
11. Attenuating the effects of cardiac arrest on hepatic drug metabolism: just chill out! Boucher BA Crit Care Med; 2009 Jan; 37(1):369-70. PubMed ID: 19112312 [No Abstract] [Full Text] [Related]
12. Hepatic drug metabolism in critical illness. McKindley DS; Hanes S; Boucher BA Pharmacotherapy; 1998; 18(4):759-78. PubMed ID: 9692650 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic changes in critical illness. Boucher BA; Wood GC; Swanson JM Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacology in critical illness]. Buylaert WA Verh K Acad Geneeskd Belg; 2001; 63(5):475-80; discussion 480-2. PubMed ID: 11813504 [TBL] [Abstract][Full Text] [Related]
15. Altered pharmacology in the Intensive Care Unit patient. Zagli G; Tarantini F; Bonizzoli M; Di Filippo A; Peris A; De Gaudio AR; Geppetti P Fundam Clin Pharmacol; 2008 Oct; 22(5):493-501. PubMed ID: 18684127 [TBL] [Abstract][Full Text] [Related]